我国专利药价格谈判品种遴选及评价体系研究

发布时间：2018-03-09 09:13

本文选题：药价谈判　切入点：专利药　出处：《上海医药工业研究院》2017年硕士论文　论文类型：学位论文

【摘要】：多年以来,我国药品价格虚高现象屡见不鲜,尤其是进口的专利药品由于临床疗效突出,加之缺乏市场竞争,在我国长期处于垄断地位,药品价格普遍居高不下。专利药品由于具有一定的市场保护期限,无法与普通药品一样,以市场竞争形成药品价格,因此,需要采取统一谈判的方式,将专利药品价格控制在合理的区间范围内,谈判模式形成专利药价格也是国际通行的方式。目前我国的药品价格谈判工作尚处于初探阶段,没有形成成熟系统的药品价格谈判模式。为了给国家谈判工作中品种的选择提供一定参考,最终完善我国药价谈判的制度体系,本文立足于国家药品价格谈判的品种,从专利药品种角度出发,深入分析专利药产品的特征和使用现状,首先对专利药产品提出遴选原则和筛选办法,其次对专利药品相关影响因素进行具体分析,筛选出重要的评价指标,赋予相对合理的权重,并通过首批谈判品种对结果进行验证,最终形成专利药价格谈判品种的评价体系。本文的研究方法有六种,分别是专家咨询、文献调研、调查问卷、实证验证、定性分析和定量统计分析法。通过对专利药利益相关方的分析,确定了专利药谈判品种的五大遴选原则;并从疾病、品种和企业三个角度阐述了专利药谈判品种遴选的具体方法;最后从不同角度分析专利药谈判品种相关指标,形成了5个维度的初级指标,14个定性指标以及众多观测指标。通过问卷调查和专家咨询的方式对二级指标赋予一定权重,其次对指标体系进行实证研究,根据观测指标对专利药产品进行具体的衡量和评价,形成专利药产品评价的最终结果。通过首批谈判的三个品种,对评价体系进行进一步的验证,三个品种评价的结果均为有谈判价值,表明指标体系较为合理。本文的创新点主要在于选题新颖,研究内容具有实际意义,研究成果具有前瞻性。国家药品价格谈判正处于首批试点阶段,是当前国家的热点话题,本文通过定性结合定量的方法,理论结合实证的方法,以及专家咨询的方法,针对谈判品种进行深入研究。
[Abstract]:For many years, the phenomenon of false high drug prices has been common in our country, especially because of the outstanding clinical efficacy of imported patented drugs and the lack of market competition, they have been in a monopoly position for a long time in our country. Drug prices are generally high. Because patent drugs have a certain period of market protection, they are unable to form drug prices in the same way as ordinary medicines by market competition. Therefore, it is necessary to adopt a unified negotiation method. To control the price of patent drugs within a reasonable range, the negotiation mode is also a common mode in the world. At present, the negotiation of drug prices in our country is still in the preliminary stage. In order to provide a certain reference for the selection of varieties in the national negotiations and finally perfect the institutional system of drug price negotiations in China, this paper is based on the varieties of the national drug price negotiations. From the point of view of the variety of patent drugs, the characteristics and current situation of patent drug products are analyzed in depth. Firstly, the selection principles and screening methods of patent drug products are put forward. Secondly, the related factors of patent drugs are analyzed concretely. The important evaluation index is screened out, the relative reasonable weight is given, and the result is verified by the first batch of negotiated varieties. Finally, the evaluation system of the patented drug price negotiation variety is formed. There are six kinds of research methods in this paper, which are expert consultation, respectively. Literature investigation, questionnaire, empirical verification, qualitative analysis and quantitative statistical analysis. Through the analysis of the stakeholders of patent drugs, the paper determines the five principles of selection of patent drugs negotiated varieties; and from the disease, This paper expounds the specific methods of variety selection in patent drug negotiation from three angles: variety and enterprise. Finally, it analyzes the related indexes of patent drug negotiation from different angles. It forms five dimensions of primary indicators, 14 qualitative indicators and many observation indicators. Through questionnaires and expert consultation, the secondary indicators are given a certain weight, and then the index system is empirically studied. According to the measurement and evaluation of the patent drug products, the final results of the patent drug product evaluation are formed. The evaluation system is further verified through the first three negotiated varieties. The results of the evaluation of the three varieties are of negotiation value, indicating that the index system is reasonable. The innovation of this paper is mainly due to the novelty of the selected topics and the practical significance of the research contents. The research results are forward-looking. The national drug price negotiations are in the first pilot stage, which is a hot topic in our country. This paper combines qualitative and quantitative methods, theoretical and empirical methods, as well as expert consultation methods. Carry on the thorough research to the negotiation variety.
【学位授予单位】：上海医药工业研究院
【学位级别】：硕士
【学位授予年份】：2017
【分类号】：R95

【相似文献】